Abstract

We evaluated the effects of an adenylate cyclase activator, N, N-dimetyl-β-alanine[3 R-(3α,4αβ,5β,6β,6 aα,10α,10 aβ,10 bα)]-5(acetyloxy)-3-ethenyldodecahydro-10,10 b-dihydroxy-3,4 a,7,7,10 a-pentamethyl-1-oxo-1 H-naphtho[2,1-b]pyran-6-yl ester hydrochloride (NKH477), on neural control of renal functions in anesthetized dogs. Renal nerve stimulation (2 Hz) increased renal norepinephrine efflux and reduced renal blood flow, glomerular filtration rate, urine flow rate, urinary Na + excretion and fractional Na + excretion. Intrarenal arterial infusion of NKH477 (300 ng/kg/min) suppressed the stimulation-induced reductions in renal blood flow and glomerular filtration rate and attenuated the reductions in urine flow rate and urinary Na + excretion but not the changes in renal norepinephrine efflux and fractional Na + excretion. Infusion of NKH477 did not affect the urinary responses induced by renal nerve stimulation at a lower frequency (0.5–1 Hz) which had little influence on renal blood flow and glomerular filtration rate. The present results demonstrate that NKH477 inhibits renal vasoconstriction and hypofiltration but not the enhanced tubular Na + reabsorption during activation of the renal sympathetic nervous system.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.